Evidence map›Paper›PMID 36354542›Full record

ReviewBioengineering (Basel, Switzerland)2022

Utilization of Nanotechnology to Improve Bone Health in Osteoporosis Exploiting

Javed Ahmad, Hassan A Albarqi, Mohammad Zaki Ahmad, Mohamed A A Orabi, Shadab Md, Ritam Bandopadhyay, Faraha Ahmed, Mohammad Ahmed Khan, Javed Ahamad, Awanish Mishra

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Javed AhmadDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia.ORCID 0000-0002-7025-751X
Hassan A AlbarqiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia.ORCID 0000-0002-1902-2328
Mohammad Zaki AhmadDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia.ORCID 0000-0003-2979-8776
Mohamed A A OrabiDepartment of Pharmacognosy, College of Pharmacy, Najran University, Najran 11001, Saudi Arabia.ORCID 0000-0002-4288-6829
Shadab MdDepartment of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-9343-1066
Ritam BandopadhyayDepartment of Pharmacology, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0001-9339-3285
Faraha AhmedDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, Hamdard Nagar 110062, New Delhi, India.ORCID 0000-0001-5438-0350
Mohammad Ahmed KhanDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, Hamdard Nagar 110062, New Delhi, India.
Javed AhamadDepartment of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil 44001, Iraq.ORCID 0000-0002-9445-5879
Awanish MishraDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Changsari, Kamrup 781101, Assam, India.ORCID 0000-0001-7863-5581
Najran University · SAJamia Hamdard · INAl-Azhar University · EGKing Abdulaziz University · SALovely Professional University · INNational Institute of Pharmaceutical Education and Research · INTishk International University · IQ

Funding

Deanship of Scientific Research at Najran University, Saudi Arabia NU/RC/MRC/11/4
6 · The paper itself

Abstract

Osteoporosis, a chronic bone disorder, is one of the leading causes of fracture and morbidity risk. Numerous medicinally important herbs have been evaluated for their efficacy in improving bone mass density in exhaustive preclinical and limited clinical studies.

Indexed as

anti-inflammatoryantioxidantnanotechnology-mediated drug deliverynano-thymoquinoneNigella sativaosteoporosisthymoquinone

Identifiers

PMID36354542
PMCPMC9687452
OpenAlexW4307921830

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.